High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC).
Myrto K MoutafiKatherine M BatesThazin Nwe AungRolando Garcia MilianVasiliki XirouIoannis A VathiotisNiki GavrielatouAthanasios AngelakisKurt A SchalperLeonidas SalichosDavid L RimmPublished in: Journal for immunotherapy of cancer (2024)
as potential indicative biomarkers of resistance to PD-1 axis blockade that might help to improve precision immunotherapy strategies for lung cancer.